Chase Medical Research

What Chase Medical Research does

Chase Medical Research (CMR) is a Connecticut-based clinical trial site organization operating two free-standing research facilities in Waterbury and Hamden. Founded around 2000 by Dr. Joseph Soufer and incorporated as an independent entity in 2006, CMR conducts Phase I through Phase IV clinical trials across twelve therapeutic areas including endocrinology, obesity, vaccines, cardiovascular disease, nephrology, medical devices, pain management, musculoskeletal conditions, central nervous system disorders, gastrointestinal conditions, urology, and women's health. The organization has executed more than 400 clinical trials for over 170 sponsors and contract research organizations (CROs), with particular depth in cardiometabolic indications (250+ diabetic trials, 22+ obesity trials, 40+ pain management trials) and vaccine research.

CMR's underlying technology stack is purpose-built for multi-therapeutic site operations rather than software development. Core technical capabilities include Institutional Biosafety Committee (IBC) certification and a Connecticut Yellow Fever Vaccination Stamp at the Waterbury site (enabling vaccine trials with biological agents), decentralized/virtual trial infrastructure for remote visits, EHR data mining tools used against affiliated physician practice records to identify eligible subjects, and ALCOA+ data integrity frameworks. The combined research footprint spans 16,050 square feet, and the company maintains a proprietary patient database exceeding 75,000 individuals within a 15-20 mile radius of its sites, which sits within a broader catchment area of 750,000+ potential subjects. Staff hold GCP, HSR, and IPS CITI certifications.

Revenue is generated through professional-services contracts with pharmaceutical, biotechnology, and CRO sponsors who pay CMR on a per-trial basis to conduct site operations, recruit and retain patients, collect clinical data, and deliver regulatory-grade outputs. Go-to-market is a sales-led enterprise motion run by a dedicated business development function that monitors pharma/CRO pipelines and pursues feasibility wins; the company has completed over 4,000 feasibility questionnaires across its history. The customer mix is predominantly enterprise (large pharma and biotech sponsors plus CROs), with a secondary persona of individual clinical trial participants who receive study-related care at no cost and may be compensated for time and travel. In March 2026, CMR was acquired by Nashville-based multisite research company PhaseWell Research, becoming part of a broader national site network while continuing to operate its Connecticut locations.

Name

Chase Medical Research

Legal name

Chase Medical Research, LLC

Website

https://chasemr.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Chase Medical Research is a Connecticut-based clinical trial site network operating two facilities that conduct Phase I-IV trials across 12 therapeutic areas for pharmaceutical, biotech, and CRO sponsors. Acquired by PhaseWell Research in March 2026.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical CROs (Phase I–IV) (HLAGAAAA), Clinical Trial Patient Recruitment & Retention (HLAGACAD), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

• Clinical trial site services
• Phase I-IV trials
• Patient recruitment services
• Therapeutic area research
• Vaccine clinical trials

Headquarters

HQ city

Waterbury

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Trial Services: CMR conducts clinical trials for pharmaceutical companies, biotech firms, and CROs. Revenue is generated through contractual agreements with sponsors for conducting Phase I-IV clinical trials across multiple therapeutic areas. The company has worked with over 170 sponsors and CROs.
2. Patient Recruitment Services: Provides patient recruitment and retention services for clinical trials, utilizing a database of over 75,000 patients within 15-20 miles of their locations.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels10 records

Core offering

Chase Medical Research operates two free-standing clinical research sites in Waterbury and Hamden, Connecticut that conduct Phase I through Phase IV clinical trials for pharmaceutical companies, biotech firms, and Contract Research Organizations (CROs) across twelve therapeutic areas. The company provides site management, patient recruitment, regulatory compliance, and virtual/decentralized trial capabilities, with access to a database of more than 75,000 patients within a 750,000+ catchment area.

Product overview

Chase Medical Research is a multi-site clinical research organization offering a unified clinical trial site management platform. The company operates two free-standing clinical research sites in Waterbury and Hamden, Connecticut (Chase Medical Research, LLC and CMR of Greater New Haven, LLC), conducting Phase I through Phase IV clinical trials across 12 therapeutic areas including Endocrinology, Obesity, Vaccines, Cardiovascular, Nephrology, Devices, Pain Management, Musculoskeletal, Central Nervous System, Gastrointestinal, Urology, and Women's Health. The core service includes comprehensive clinical trial management with patient recruitment capabilities, site feasibility assessment, regulatory compliance, and virtual trial capabilities. The company was founded over 20 years ago by Dr. Joseph Soufer and was acquired by PhaseWell Research in March 2026.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Site Management Services Multi-site clinical research services conducting Phase I through Phase IV clinical trials across twelve therapeutic areas from sites in Waterbury and Hamden, Connecticut, serving a catchment area of over 750,000 potential patient subjects. Services are contracted with pharmaceutical sponsors, biotech firms, and CROs.
• Endocrinology Clinical Trials Clinical trials for endocrine conditions including Type 2 Diabetes, Diabetic Peripheral Neuropathy, Osteoporosis, Fatty Liver Disease, and Non-Alcoholic Steatohepatitis (NASH). Over 250 diabetic clinical trials conducted to date.
• Obesity Clinical Trials Clinical trials for weight loss in individuals with and without diabetes, including trials with GLP-1 agonists such as Semaglutide and Liraglutide.
• Vaccine Clinical Trials Vaccine trials including mRNA trials for Influenza, Respiratory Syncytial Virus, COVID, Lyme Disease, Meningitis, and other vaccine-preventable diseases.
• Cardiovascular Disease Clinical Trials Clinical trials for cardiovascular conditions including Hypertension, Hyperlipidemia, Atrial Fibrillation, and Coronary Artery Disease.
• Nephrology Clinical Trials Clinical trials for kidney conditions including Chronic Kidney Disease, Diabetic Kidney Disease, and Chronic Kidney Disease with Anemia.
• Device Clinical Trials Clinical trials for medical devices including Continuous Glucose Monitors (CGMs), Insulin Delivery Systems, Intraarticular Injections, and Motility Tracking Devices.
• Pain Management Clinical Trials Over 40 clinical trials for chronic pain conditions including Diabetic Peripheral Neuropathy, Osteoarthritis, Chronic Low Back Pain, and Migraine using monoclonal antibodies and biologics.
• Musculoskeletal Clinical Trials Clinical trials for Osteoarthritis of the Knee, Osteoarthritis of the Hip, and Low Back Pain using hyaluronic acid, analgesics, and anti-inflammatories.
• Central Nervous System Clinical Trials Clinical trials for neurological conditions including Episodic and Chronic Migraine, Dementia, and Mild Cognitive Impairment using monoclonal antibodies and biologics.
• Gastrointestinal Clinical Trials Clinical trials for GI conditions including Fatty Liver Disease, NASH, Gastroesophageal Reflux Disease (GERD), and Irritable Bowel Syndrome (IBS-C and IBS-D).
• Urology Clinical Trials Clinical trials for urological conditions including Overactive Bladder and Erectile Dysfunction.
• Women's Health Clinical Trials Clinical trials for women's health conditions including Overactive Bladder, Oral Contraception, Osteoporosis, and Hot Flashes in Menopausal Women.
• Patient Recruitment Services Comprehensive recruitment services utilizing marketing campaigns, EHR data mining, social media, community outreach, and a database of over 75,000 patients within 15-20 miles of CMR's sites to meet sponsor enrollment goals.
• Virtual Trial Capabilities Decentralized clinical trial capabilities allowing sponsors and CROs to conduct trials with virtual/decentralized visits using the CMR site for remote patient monitoring and virtual participation.

Quantifiable outcome

• 99% exceeded enrollment goals in vaccine/healthy trials
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• PhaseWell ResearchcoreStrategic or Co-development Partner · 1 March 2026PhaseWell Research, a Nashville-based multisite clinical research company, acquired Chase Medical Research. The acquisition expands PhaseWell's growing Northeast footprint and broadens its capabilities in cardiometabolic and central nervous system clinical trials. Chase Medical Research will continue operating its Connecticut locations while extending its cardiometabolic expertise across PhaseWell's national network.

Scale indicators14 records

Recent moves3 records

Expansion highlights6 records

Broad incumbents

• Syneos Health: Biopharmaceutical solutions organization combining CRO services with site network operations. Broad incumbent competing for the same sponsor trials across multiple therapeutic areas.
• IQVIA: Largest global CRO/SMO incumbent that operates its own site network and manages sponsor trials at scale. Competes with CMR for trial placement and offers a one-stop-shop alternative to sponsors.
• Labcorp Drug Development: Major clinical laboratory and CRO offering central lab plus site services to sponsors. Competes indirectly by offering integrated lab and trial delivery that CMR partners with for specimen handling.
• ICON plc: Global CRO providing clinical trial site management and full-service trial delivery. Competes broadly for sponsor contracts and consolidates site relationships at scale.

Emerging players

• QPS Holdings: Contract research organization with Phase I clinical pharmacology units and bioanalytical services. Overlaps with CMR in early-phase clinical trial execution and specialized therapeutic areas.

Direct peers

• Benchmark Research: Multisite SMO operating community-based clinical trial sites with a similar investigator-led model. Direct competitor for sponsor trials, particularly in vaccine and cardiometabolic indications.
• PhaseWell Research: Nashville-based multisite clinical research company that acquired Chase Medical Research in March 2026. Operates the same SMO/site-network model across cardiometabolic, CNS, and other therapeutic areas, making it the closest strategic and operational peer.
• Clinvest Research: Clinical research site network with a similar multi-therapeutic, community-based trial execution model. Direct competitor in site selection for sponsor and CRO awards.
• Accel Research Sites: Integrated clinical research site network conducting Phase I–IV trials across multiple therapeutic areas. Comparable multisite SMO competing for the same sponsor/CRO business.
• Velocity Clinical Research: Large multisite clinical research site network focused on therapeutic-area specialization and high enrollment performance. Competes directly with CMR for sponsor awards across Phase I–IV trials.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

• Xx.com/chase_research
• LinkedInlinkedin.com/company/chase-medical-research-llc

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chase Medical Research